About soliqua 100 33?

Soliqua 100/33 is a prescription fixed-dose injectable medicine for adults with type 2 diabetes. It combines two active ingredients in one pen:

- Insulin glargine, 100 units/mL (a long-acting basal insulin)
- Lixisenatide, 33 mcg/mL (a GLP-1 receptor agonist)

What it’s used for
- To improve glycemic control in adults with type 2 diabetes when a GLP-1 receptor agonist and a basal insulin are appropriate to use together as a single daily injection.

How to use (general guidelines)
- Dose form: once daily subcutaneous injection, ideally within 1 hour before the first meal of the day.
- Starting dose: usually 15 units per day (which corresponds to 15 units insulin glargine and about 5 mcg lixisenatide per dose).
- Titration: can increase by 2–4 units every 3–4 days to reach your glucose goals.
- Maximum: the recommended maximum daily dose is 60 units (which will also deliver up to about 20 mcg lixisenatide per day).
- Do not split dosing or use more than one dose per day.

Important precautions and contraindications
- Do not use if you have had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Not for people with type 1 diabetes or diabetic ketoacidosis.
- Warnings include risk of pancreatitis with GLP-1 receptor agonists, potential thyroid C-cell tumors (including in animals), gallbladder problems, and possible hypoglycemia when used with other diabetes medicines.
- Tell your healthcare provider about all medications you take (especially other diabetes medicines like sulfonylureas or other insulins) since hypoglycemia risk can increase.

Common side effects
- Nausea, vomiting, diarrhea, or decreased appetite (common with GLP-1 therapies)
- Injection-site reactions
- Possible weight change
- Hypoglycemia can occur, especially if you’re also using other glucose-lowering medicines

Administration and safety tips
- Rotate injection sites (abdomen, outer thigh, or upper arm) to reduce skin irritation.
- Do not inject into the same exact spot repeatedly.
- Use a new needle for each injection and do not share pens.
- Store the pen as directed (typically refrigerated before first use; follow label instructions for after initial use).
- If you miss a dose, contact your clinician for guidance on re-dosing.

Who to talk to
- Always consult your doctor or a pharmacist for advice tailored to your situation, especially about dosing if you’re switching from another insulin regimen or have kidney issues, are pregnant, or have a history of pancreatitis or thyroid disease.

If you’d like, I can pull up the official prescribing information or provide a patient-friendly summary specific to your situation (e.g., what to do if you’re currently on basal insulin, how to titrate, or potential drug interactions). Do you want that?